TP53 and the Ultimate Biological Optimization Steps of Curative Radiation Oncology
The new biological interaction cross-section-based repairable–homologically repairable (RHR) damage formulation for radiation-induced cellular inactivation, repair, misrepair, and apoptosis was applied to optimize radiation therapy. This new formulation implies renewed thinking about biologically op...
Main Author: | Anders Brahme |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/17/4286 |
Similar Items
-
A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
by: Sophia Ceder, et al.
Published: (2021-02-01) -
Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants
by: Adam J. Nagourney, et al.
Published: (2023-03-01) -
Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?
by: Michael J. Duffy, et al.
Published: (2022-09-01) -
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies
by: Jolanda Magri, et al.
Published: (2021-01-01) -
Dual Nucleosomal Double-Strand Breaks Are the Key Effectors of Curative Radiation Therapy
by: Anders Brahme, et al.
Published: (2023-12-01)